- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01461694
Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser
May 11, 2012 updated by: Adam Gilmour, NHS Greater Glasgow and Clyde
Comparison of Intense Pulsed Light System 650 Advance Hand-Piece and Alexandrite Laser for Female Facial Hair Reduction
The purpose of this study is to compare the efficacy of the IPL system 650advance handpiece with the alexandrite laser for the purposes of female facial hair reduction
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a randomised (splitface)controlled trial, comparing the use of the Intense Pulsed Light (IPL) system 650 advance handpiece against the Alexandrite Laser for the purposes of female facial hair reduction.
Previous studies have shown that the alexandrite laser is superior to IPL in achieving hair reduction.
A new handpiece (Lynton, Lumina 650 advance) available for the IPL system is designed to further optimise its use in removing female facial hair (particularly those hair colours previously unresponsive to treatment).
This study will compare the alexandrite laser to the IPL system using the new handpiece.
This may lead to improvements in the treatment of female patients with male pattern facial hair.
Female patients referred to our facial hair reduction service will be recruited to this study.
1/2 their face will be treated with IPL and 1/2 with alexandrite laser.
Each participant will receive 6 full treatments at approximately 6 weekly intervals.
Participants will be asked to fill in a satisfaction questionnaire and have clinical photographs taken pre treatment and at 1 and 3months post final treatment.
All treatments will be carried out in our dedicated laser suite at Glasgow Royal Infirmary.
Study Type
Interventional
Enrollment (Anticipated)
35
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Glasgow, United Kingdom, G4 0SF
- Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female Patients
- Minimum age 16years old
- Fitzpatrick skin types I-III
- Significant facial hair.
Exclusion Criteria:
- Fitzpatrick skin types IV-VI
- Age less than 16years old
- Males
- No visible facial hair growth
- Use of electrolysis or depilatory creams 6weeks prior to treatment
- Active acnes
- Current coldsore
- Previous facial hair removal with laser or IPL in past 12 months
- Sun tanned skin
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: IPL
Half face treated with IPL
|
Half Face Treated with IPL
|
|
Active Comparator: Alexandrite Laser
Half face treated with Alexandrite Laser
|
Half face treated with Alexandrite Laser
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in total Hair Count measurement at 1month post final treatment from baseline
Time Frame: Baseline and 1 month
|
Pre Treatment hair count assessed using videomicroscopy as baseline.
Post final treatment hair counts will be measured again at 1month to assess if there has been a reduction in total hair count from pre-treatment
|
Baseline and 1 month
|
|
Change in total hair count at 3months post final treatment from baseline
Time Frame: Baseline and 3months post final treatment
|
Pre Treatment hair count assessed using videomicroscopy as baseline.
Post final treatment hair counts will be measured again at 3months to assess if there has been a reduction in total hair count from pre-treatment
|
Baseline and 3months post final treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adam Gilmour, MBChB, MRCS (Ed), NHS Greater Glasgow & Clyde
- Study Chair: Iain Mackay, MBChb, MRCS, FRCS (plast), NHS Greater Glasgow & Clyde
- Study Director: Vivek Sivarajan, MBChB, MRCS, MD, FRCS (Plas), NHS Greater Glasgow & Clyde
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Anticipated)
March 1, 2013
Study Completion (Anticipated)
March 1, 2013
Study Registration Dates
First Submitted
October 25, 2011
First Submitted That Met QC Criteria
October 26, 2011
First Posted (Estimate)
October 28, 2011
Study Record Updates
Last Update Posted (Estimate)
May 14, 2012
Last Update Submitted That Met QC Criteria
May 11, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN11SU380
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hirsutism
-
Iran University of Medical SciencesFiruzgar hospital affiliated to Iran University of Medical SciencesCompletedIdiopathic Hirsutism
-
Alexander ShayestehRecruitingHypertrichosis | Hirsutism - HypertrichosisSweden
-
Istanbul Medeniyet UniversityUnknown
-
Bispebjerg HospitalCompleted
-
Khyber Teaching HospitalRecruiting
-
Medical Life Care Planners, LLCNot yet recruitingHair Diseases | Hirsutism
-
Follicum ABCompletedAlopecia | Hirsutism | HypertrichosisGermany
-
BayerCompletedProstate Cancer | Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea | Hypersexuality in Men | Sexual Deviations in MenSpain, Germany, Netherlands, Poland, France
Clinical Trials on Intense Pulsed Light (IPL)
-
Second Xiangya Hospital of Central South UniversityRecruitingFacial Telangiectasia in Patients With Systemic Lupus ErythematosusChina
-
Goldman, Butterwick, Fitzpatrick and GroffNot yet recruitingKeratosis Pilaris
-
Samsung Medical CenterCompletedMeibomian Gland DysfunctionKorea, Republic of
-
Lumenis Be Ltd.CompletedDry Eye | Meibomian Gland DysfunctionIsrael
-
Chulalongkorn UniversityRecruitingMGD-Meibomian Gland DysfunctionThailand
-
Mayo ClinicCompleted
-
Clinique TrenelProSurgNot yet recruitingCataract Surgery | Eye DrynessFrance
-
Cutera Inc.Completed
-
Hospital de Clinicas de Porto AlegreUnknownPeriorbital DisorderBrazil